Title:
低減された抗原用量を有するブースターワクチンの製造
Document Type and Number:
Japanese Patent JP5090452
Kind Code:
B2
Abstract:
A process for manufacturing a vaccine, wherein the vaccine comprises diphtheria toxoid and tetanus toxoid and, and wherein the process comprises steps of combining (i) a first bulk comprising diphtheria toxoid and tetanus toxoid with (ii) a second bulk comprising tetanus toxoid but no diphtheria toxoid. This arrangement facilitates convenient manufacture of both pediatric and adolescent vaccines from the same bulks: the first bulk can have a diphtheriartetanus ratio that is suitable for pediatric vaccines, and the second bulk can be used to reduce the relative amount of diphtheria toxoid, as found in the adolescent vaccines.
Inventors:
Frings, eric
Hunger, Christoph
Hunger, Christoph
Application Number:
JP2009524255A
Publication Date:
December 05, 2012
Filing Date:
August 15, 2007
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K39/116; A61K39/05; A61K39/08; A61K39/10; A61K39/13; A61K39/295; A61K39/39; A61P31/04
Domestic Patent References:
| JP2000504032A | ||||
| JP2001503422A | ||||
| JP2003525858A | ||||
| JP7508267A | ||||
| JP2004517866A |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita